GlucoSentient, Inc SBIR Phase I Award, April 2021
A SBIR Phase I contract was awarded to Glucosentient, Inc. in April, 2021 for $224,018.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Is a
Award Amount (USD)
224,018
0
Government Branch
Date Awarded
April 1, 2021
0
End Date
February 28, 2022
0
SBIR/STTR Award Recipient
Contract Number (US Government)
1R43AI162165-01
0
Award Phase
Phase I
0
Award Type
SBIR
0
Official Website
Find more entities like GlucoSentient, Inc SBIR Phase I Award, April 2021
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.